PT Biometrik Riset Indonesia Reinforces Commitment to National Standards Through BPOM Audit
Writer: dr. Ria Oktavia
Depok, November 24th 2025 – The Bioavailability and Bioequivalence (BA/BE) Center of PT Biometrik Riset Indonesia welcomed an audit by the Indonesian Food and Drug Authority (BPOM) as part of the regulatory assessment to ensure compliance with national standards for BA/BE study implementation.
The audit team from BPOM carried out a comprehensive review of the facilities, including laboratory operations, documentation systems, drug storage conditions, temperature monitoring, operational SOPs, and the conduct of both clinical and bioanalytical phases of the studies.
The ...